Literature DB >> 30275119

Regional Differences in Human Intestinal Drug Metabolism.

Raditya Iswandana1, Marina I Irianti1, Dorenda Oosterhuis1, Hendrik S Hofker1, Marjolijn T Merema1, Marina H de Jager1, Henricus A M Mutsaers1, Peter Olinga2.   

Abstract

The intestines are key for the absorption of nutrients and water as well as drug metabolism, and it is well known that there are clear differences in the expression profile of drug metabolism enzymes along the intestinal tract. Yet only a few studies have thoroughly investigated regional differences in human intestinal drug metabolism. In this study, we evaluated phase I and phase II metabolism in matched human ileum and colon precision-cut intestinal slices (PCIS). To this end, human PCIS were incubated for 3 hours with testosterone and 7-hydroxycoumarin (7-HC) to examine phase I and phase II metabolism, respectively. Metabolite formation was assessed by high-performance liquid chromatography analysis. Our results demonstrated that androstenedione, 6β-hydroxytestosterone, 2β-hydroxytestosterone, and 7-HC sulfate were predominantly formed in the ileum, while 15α-hydroxytestosterone and 7-HC glucuronide were mainly produced in the colon. Moreover, we also observed sex differences in phase II metabolite formation, which appeared to be higher in men compared with women. Taken together, we demonstrated that phase I metabolism predominantly occurs in ileum PCIS, while phase II metabolism mostly takes place in colon PCIS. Moreover, we revealed that human PCIS can be used to study both regional and sex differences in intestinal metabolism.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30275119     DOI: 10.1124/dmd.118.083428

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

Review 1.  Age-related changes in intestinal immunity and the microbiome.

Authors:  Travis Walrath; Kiran U Dyamenahalli; Holly J Hulsebus; Rebecca L McCullough; Juan-Pablo Idrovo; Devin M Boe; Rachel H McMahan; Elizabeth J Kovacs
Journal:  J Leukoc Biol       Date:  2020-10-05       Impact factor: 6.011

2.  A Transcriptomic Approach to Elucidate the Mechanisms of Gefitinib-Induced Toxicity in Healthy Human Intestinal Organoids.

Authors:  Daniela Rodrigues; Bram Herpers; Sofia Ferreira; Heeseung Jo; Ciarán Fisher; Luke Coyle; Seung-Wook Chung; Jos C S Kleinjans; Danyel G J Jennen; Theo M de Kok
Journal:  Int J Mol Sci       Date:  2022-02-17       Impact factor: 5.923

3.  Extending the viability of human precision-cut intestinal slice model for drug metabolism studies.

Authors:  C Biel; O Martinec; B Sibering; K van Summeren; A M A Wessels; D J Touw; K P de Jong; V E de Meijer; K N Faber; J P Ten Klooster; I A M de Graaf; P Olinga
Journal:  Arch Toxicol       Date:  2022-04-15       Impact factor: 6.168

4.  A Proximal-to-Distal Survey of Healthy Adult Human Small Intestine and Colon Epithelium by Single-Cell Transcriptomics.

Authors:  Joseph Burclaff; R Jarrett Bliton; Keith A Breau; Meryem T Ok; Ismael Gomez-Martinez; Jolene S Ranek; Aadra P Bhatt; Jeremy E Purvis; John T Woosley; Scott T Magness
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-02-15

5.  Inter-individual and inter-regional variations in enteric drug metabolizing enzyme activities: Results with cryopreserved human intestinal mucosal epithelia (CHIM) from the small intestines of 14 donors.

Authors:  Albert P Li; Ming-Chih D Ho; Novera Alam; Walter Mitchell; Susan Wong; Zhengyin Yan; Jane R Kenny; Cornelis E C A Hop
Journal:  Pharmacol Res Perspect       Date:  2020-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.